Enzymatic and molecular strategies to diagnose Pompe disease

Bibliography

• Van den Hout H, Reuser AJ, Vulto AG, Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet 2000;356:397-8
   PubMed Web of Science ®Google Scholar
• Amalfitano A, Bengur AR, Morse RP, Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med 2001;3:132-8
   PubMed Web of Science ®Google Scholar
• Hers HG. Alpha-glucosidase deficiency in generalized glycogen storage disease (Pompe's disease). Biochem J 1963;86:11-6
   PubMed Web of Science ®Google Scholar
• Hirschhorn R, Reuser AJJ. Glycogen Storage Disease Type II (GSDII). In: Cr Scriver, et al, editors, The metabolic and molecular bases of inherited disease. McGraw-Hill: NY; 2001. p. 3389-420
   Google Scholar
• Van der Ploeg AT, Reuser AJ. Pompe's disease. Lancet 2008;372:1342-53
   PubMed Web of Science ®Google Scholar
• Engel AG. Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain 1970;93:599-616
   PubMed Web of Science ®Google Scholar
• Reuser AJJ, Koster JF, Hoogeveen A, Biochemical, immunological, and cell genetic studies in glycogenosis type II. Am J Hum Genet 1978;30:132-43
   PubMed Web of Science ®Google Scholar
• Howell RR, Byrne B, Darras BT, Diagnostic challenges for Pompe disease: an under-recognized cause of floppy baby syndrome. Genet Med 2006;8:289-96
   PubMed Web of Science ®Google Scholar
• Baethmann M. Clinical manifestations of Pompe disease. In: M Baethmann, V Straub, Ajj Reuser, editors, Pompe disease, UNI-MED Verlag AG: Bremen; 2008. p. 31-46
   Google Scholar
• Kishnani PS, Howell RR. Pompe disease in infants and children. J Pediatr 2004;144:S35-43
   PubMed Web of Science ®Google Scholar
• Bembi B, Cerini E, Danesino C, Diagnosis of glycogenosis type II. Neurology 2008;71:S4-11
   PubMed Web of Science ®Google Scholar
• Kishnani PS, AANEM Diagnostic criteria for late-onset (childhood and adult) pompe disease. Muscle Nerve 2009;40:149-60
   PubMed Web of Science ®Google Scholar
• Hagemans ML, Winkel LP, Van Doorn PA, Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain 2005;128:671-7
   PubMed Web of Science ®Google Scholar
• Kishnani PS, Steiner RD, Bali D, Pompe disease diagnosis and management guideline. Genet Med 2006;8:267-88
   PubMed Web of Science ®Google Scholar
• Wokke JH, Escolar DM, Pestronk A, Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle Nerve 2008;38:1236-45
   PubMed Web of Science ®Google Scholar
• Available from: http://www.pompecenter.nl
   Google Scholar
• Reuser AJJ, Kroos MA, Hermans MMP, Glycogenosis type II (acid maltase deficiency). Muscle Nerve 1995;3:S61-9
   PubMedGoogle Scholar
• Kemper AR, Hwu WL, Lloyd-Puryear M, Newborn screening for Pompe disease: synthesis of the evidence and development of screening recommendations. Pediatrics 2007;120:e1327-34
   PubMed Web of Science ®Google Scholar
• van Diggelen OP, Oemardien LF, van der Beek NA, Enzyme analysis for Pompe disease in leukocytes; superior results with natural substrate compared with artificial substrates. J Inherit Metab Dis 2009;32:416-23
   PubMed Web of Science ®Google Scholar
• Okumiya T, Keulemans JL, Kroos MA, A new diagnostic assay for glycogen storage disease type II in mixed leukocytes. Mol Genet Metab 2006;88:22-8
   PubMed Web of Science ®Google Scholar
• Jack RM, Gordon C, Scott CR, The use of acarbose inhibition in the measurement of acid alpha-glucosidase activity in blood lymphocytes for the diagnosis of Pompe disease. Genet Med 2006;8:307-12
   PubMed Web of Science ®Google Scholar
• Umapathysivam K, Hopwood JJ, Meikle PJ. Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease. Clin Chem 2001;47:1378-83
   PubMed Web of Science ®Google Scholar
• Li Y, Scott CR, Chamoles NA, Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. Clin Chem 2004;50:1785-95
   PubMed Web of Science ®Google Scholar
• Kallwass H, Carr C, Gerrein J, Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots. Mol Genet Metab 2007;90:449-52
   PubMed Web of Science ®Google Scholar
• Chien YH, Chiang SC, Zhang XK, Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Pediatrics 2008;122:e39-45
   PubMed Web of Science ®Google Scholar
• Dajnoki A, Muhl A, Fekete G, Newborn screening for Pompe disease by measuring acid alpha-glucosidase activity using tandem mass spectrometry. Clin Chem 2008;54:1624-9
   PubMed Web of Science ®Google Scholar
• Kumamoto S, Katafuchi T, Nakamura K, High frequency of acid alpha-glucosidase pseudodeficiency complicates newborn screening for glycogen storage disease type II in the Japanese population. Mol Genet Metab 2009;97:190-5
   PubMed Web of Science ®Google Scholar
• Gasparotto N, Tomanin R, Frigo AC, Rapid diagnostic testing procedures for lysosomal storage disorders: alpha-glucosidase and beta-galactosidase assays on dried blood spots. Clin Chim Acta 2009;402:38-41
   Google Scholar
• Goldstein JL, Young SP, Changela M, Screening for Pompe disease using a rapid dried blood spot method: Experience of a clinical diagnostic laboratory. Muscle Nerve 2009;40:32-6
   PubMed Web of Science ®Google Scholar
• Ausems MG, Lochman P, van Diggelen OP, A diagnostic protocol for adult-onset glycogen storage disease type II. Neurology 1999;52:851-3
   PubMed Web of Science ®Google Scholar
• Straub V. Diagnosis of Pompe disease. In: M Baethmann, V Straub, Ajj Reuser, editors, Pompe disease, UNI-MED Verlag AG: Bremen; 2008. p. 47-57
   Google Scholar
• Young SP, Stevens RD, An Y, Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry. Anal Biochem 2003;316:175-80
   PubMed Web of Science ®Google Scholar
• An Y, Young SP, Kishnani PS, Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease. Mol Genet Metab 2005;85:247-54
   Google Scholar
• Young SP, Zhang H, Corzo D, Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker. Genet Med 2009;11:536-41
   Google Scholar
• Anderson G, Smith VV, Malone M, Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders; retrospective experience of more than 2,500 cases from a single centre. J Clin Pathol 2005;58:1305-10
   PubMed Web of Science ®Google Scholar
• Bijvoet AG, van de Kamp EH, Kroos MA, Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease. Hum Mol Genet 1998;7:53-62
   PubMed Web of Science ®Google Scholar
• Thurberg BL, Lynch Maloney C, Vaccaro C, Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest 2006;86:1208-20
   PubMed Web of Science ®Google Scholar
• Schoser BG, Muller-Hocker J, Horvath R, Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol 2007;33:544-59
   PubMed Web of Science ®Google Scholar
• Lewandowska E, Wierzba-Bobrowicz T, Rola R, Pathology of skeletal muscle cells in adult-onset glycogenosis type II (Pompe disease): ultrastructural study. Folia Neuropathol 2008;46:123-33
   PubMed Web of Science ®Google Scholar
• la Marca G, Casetta B, Malvagia S, New strategy for the screening of lysosomal storage disorders: the use of the online trapping-and-cleanup liquid chromatography/mass spectrometry. Anal Chem 2009. [In press]
   Google Scholar
• Reuser AJ, Kroos M, Oude Elferink RP, Defects in synthesis, phosphorylation, and maturation of acid alpha-glucosidase in glycogenosis type II. J Biol Chem 1985;260:8336-41
   PubMed Web of Science ®Google Scholar
• Reuser AJ, Kroos M, Willemsen R, Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts. J Clin Invest 1987;79:1689-99
   PubMed Web of Science ®Google Scholar
• Winchester B, Bali D, Bodamer OA, Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting. Mol Genet Metab 2008;93:275-81
   PubMed Web of Science ®Google Scholar
• Mehler M, DiMauro S. Residual acid maltase activity in late-onset acid maltase deficiency. Neurology 1977;27:178-84
   PubMed Web of Science ®Google Scholar
• Hasilik A, Neufeld EF. Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight. J Biol Chem 1980;255:4937-45
   PubMed Web of Science ®Google Scholar
• Martiniuk F, Bodkin M, Tzall S, Identification of the base-pair substitution responsible for a human acid alpha-glucosidase allele with lower ‘affinity' for glycogen (GAA 2) and transient gene expression in deficient cells. Am J Hum Genet 1990;47:440-5
   PubMed Web of Science ®Google Scholar
• Swallow DM, Corney G, Harris H, Acid alpha-glucosidase: a new polymorphism in man demonstrable by 'affinity' electrophoresis. Ann Hum Genet 1975;38:391-406
   PubMed Web of Science ®Google Scholar
• Swallow DM, Kroos M, Van der Ploeg AT, An investigation of the properties and possible clinical significance of the lysosomal alpha-glucosidase GAA*2 allele. Ann Hum Genet 1989;53:177-84
   PubMed Web of Science ®Google Scholar
• Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963;32:338-43
   PubMed Web of Science ®Google Scholar
• Chamoles NA, Niizawa G, Blanco M, Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper. Clin Chim Acta 2004;347:97-102
   PubMed Web of Science ®Google Scholar
• Zhang H, Kallwass H, Young SP, Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease. Genet Med 2006;8:302-6
   PubMed Web of Science ®Google Scholar
• De Jesus VR, Zhang XK, Keutzer J, Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders. Clin Chem 2009;55:158-64
   PubMed Web of Science ®Google Scholar
• CLSI Standard LA4-A5. Available from: http://www.clsi.org/. [Last accessed 15 Oct 2009]
   Google Scholar
• Gelb MH, Turecek F, Scott CR, Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders. J Inherit Metab Dis 2006;29:397-404
   PubMed Web of Science ®Google Scholar
• Schulze A, Lindner M, Kohlmuller D, Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 2003;111:1399-406
   PubMed Web of Science ®Google Scholar
• Tajima Y, Matsuzawa F, Aikawa S, Structural and biochemical studies on Pompe disease and a ‘pseudodeficiency of acid alpha-glucosidase'. J Hum Genet 2007;52:898-906
   PubMed Web of Science ®Google Scholar
• Kroos MA, Mullaart RA, Van Vliet L, p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease? Eur J Hum Genet 2008;16:875-9
   PubMed Web of Science ®Google Scholar
• Martiniuk F, Mehler M, Pellicer A, Isolation of a cDNA for human acid alpha-glucosidase and detection of genetic heterogeneity for mRNA in three alpha-glucosidase-deficient patients. Proc Natl Acad Sci USA 1986;83:9641-4
   PubMed Web of Science ®Google Scholar
• Hoefsloot LH, Hoogeveen-Westerveld M, Kroos MA, Primary structure and processing of lysosomal alpha-glucosidase; homology with the intestinal sucrase-isomaltase complex. EMBO J 1988;7:1697-704
   PubMed Web of Science ®Google Scholar
• Hoefsloot LH, Hoogeveen-Westerveld M, Reuser AJJ, Characterization of the human lysosomal alpha-glucosidase gene. Biochem J 1990;272:493-7
   PubMed Web of Science ®Google Scholar
• Martiniuk F, Mehler M, Tzall S, Sequence of the cDNA and 5′-flanking region for human acid alpha-glucosidase, detection of an intron in the 5′ untranslated leader sequence, definition of 18-bp polymorphisms, and differences with previous cDNA and amino acid sequences. DNA Cell Biol 1990;9:85-94
   PubMed Web of Science ®Google Scholar
• Available from: http://www.pompecenter.nl/reference_sequence_cdna.pdf
   Google Scholar
• Huie ML, Chen AS, Tsujino S, Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T–> G) mutation in a majority of patients and a novel IVS10 (+1GT–>CT) mutation. Hum Mol Genet 1994;3:2231-6
   PubMed Web of Science ®Google Scholar
• Montalvo AL, Bembi B, Donnarumma M, Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II. Hum Mutat 2006;27:999-1006
   PubMed Web of Science ®Google Scholar
• Kroos MA, Pomponio RJ, Hagemans ML, Broad spectrum of Pompe disease in patients with the same c.-32-13T-> G haplotype. Neurology 2007;68:110-5
   PubMed Web of Science ®Google Scholar
• Laforet P, Nicolino M, Eymard PB, Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology 2000;55:1122-8
   PubMed Web of Science ®Google Scholar
• Slonim AE, Bulone L, Goldberg T, Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 2007;35:70-7
   PubMed Web of Science ®Google Scholar
• Slonim AE, Bulone L, Minikes J, Benign course of glycogen storage disease type IIb in two brothers: nature or nurture? Muscle Nerve 2006;33:571-4
   PubMed Web of Science ®Google Scholar
• Huie ML, Chen AS, Brooks SS, A de novo 13 nt deletion, a newly identified C647W missense mutation and a deletion of exon 18 in infantile onset glycogen storage disease type II (GSDII). Hum Mol Genet 1994;3:1081-7
   PubMed Web of Science ®Google Scholar
• Van der Kraan M, Kroos MA, Joosse M, Deletion of exon 18 is a frequent mutation in glycogen storage disease type II. Biochem Biophys Res Commun 1994;203:1535-41
   PubMed Web of Science ®Google Scholar
• Hermans MM, De Graaff E, Kroos MA, The effect of a single base pair deletion (delta T525) and a C1634T missense mutation (pro545leu) on the expression of lysosomal alpha-glucosidase in patients with glycogen storage disease type II. Hum Mol Genet 1994;3:2213-8
   PubMed Web of Science ®Google Scholar
• Kroos MA, van Leenen D, Verbiest J, Glycogen storage disease type II: identification of a dinucleotide deletion and a common missense mutation in the lysosomal alpha-glucosidase gene. Clin Genet 1998;53:379-82
   PubMed Web of Science ®Google Scholar
• Ausems MG, ten Berg K, Kroos MA, Glycogen storage disease type II: birth prevalence agrees with predicted genotype frequency. Community Genet 1999;2:91-6
   PubMedGoogle Scholar
• Bodamer O, Haas D, Hermans M, L-alanine supplementation in late infantile glycogen storage disease type II. Pedtar Neurol 2002;27:145-6
   PubMed Web of Science ®Google Scholar
• Gort L, Coll MJ, Chabas A. Glycogen storage disease type II in Spanish patients: high frequency of c.1076-1G> C mutation. Mol Genet Metab 2007;92:183-7
   PubMed Web of Science ®Google Scholar
• Pittis MG, Donnarumma M, Montalvo AL, Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease. Hum Mutat 2008;29:E27-36
   PubMedGoogle Scholar
• Adams EM, Becker JA, Griffith L, Glycogenosis type II: a juvenile-specific mutation with an unusual splicing pattern and a shared mutation in African Americans. Hum Mutat 1997;10:128-34
   PubMed Web of Science ®Google Scholar
• Becker JA, Vlach J, Raben N, The African origin of the common mutation in African American patients with glycogen-storage disease type II [letter]. Am J Hum Genet 1998;62:991-4
   PubMed Web of Science ®Google Scholar
• Shieh JJ, Lin CY. Frequent mutation in Chinese patients with infantile type of GSD II in Taiwan: evidence for a founder effect. Hum Mutat 1998;11:306-12
   PubMed Web of Science ®Google Scholar
• Lin CY, Shieh JJ. Molecular study on the infantile form of Pompe disease in Chinese in Taiwan. Chung Hua Min Kuo Hsiao Erh Ko i Hsueh Hui Tsa Chih 1996;37:115-21
   Google Scholar
• Boerkoel CF, Exelbert R, Nicastri C, Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 1995;56:887-97
   PubMed Web of Science ®Google Scholar
• Hermans MM, de Graaff E, Kroos MA, Identification of a point mutation in the human lysosomal alpha-glucosidase gene causing infantile glycogenosis type II. Biochem Biophys Res Commun 1991;179:919-26
   PubMed Web of Science ®Google Scholar
• Kroos M, Pomponio RJ, van Vliet L, Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating. Hum Mutat 2008;29:E13-26
   PubMedGoogle Scholar
• Meusser B, Hirsch C, Jarosch E, ERAD: the long road to destruction. Nat Cell Biol 2005;7:766-72
   PubMed Web of Science ®Google Scholar
• Hasilik A, Waheed A, Von Figura K. Enzymatic phosporylation of lysosomal enzymes in the presence of UDP-N-acetylglucosamine. Absence of the activity in I-cell fibroblasts. Biochem Biophys Res Commun 1981;98:761-7
   PubMed Web of Science ®Google Scholar
• Sugawara K, Saito S, Sekijima M, Structural modeling of mutant alpha-glucosidases resulting in a processing/transport defect in Pompe disease. J Hum Genet 2009;54:324-30
   PubMed Web of Science ®Google Scholar
• Kleijer WJ, van der Kraan M, Kroos MA, Prenatal diagnosis of glycogen storage disease type II: enzyme assay or mutation analysis? Pediatr Res 1995;38:103-6
   PubMed Web of Science ®Google Scholar
• Reuser AJ. Prenatal diagnosis of Pompe disease. In: M Baethmann, V Straub, Ajj Reuser, editors, Pompe disease, UNI-MED Verlag AG: Bremen; 2008. p. 59-63
   Google Scholar
• Reuser AJJ, Kroos MA. Pompe disease-glycogenosis type II, acid maltase deficiency. In: Ja Barranger, Ma Cabrera-Salazar, editors, Lysosomal storage disorders, Springer Science+Business Media, LLC: New York; 2007. p. 473-98
   Google Scholar